Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Iovance Biotherapeutics (IOVA) over the last 6 years, with Dec 2024 value amounting to $124.0 million.

  • Iovance Biotherapeutics' Other Operating Expenses rose 15.12% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.0 million, marking a year-over-year increase of 130.26%. This contributed to the annual value of $124.0 million for FY2024, which is 1052.91% up from last year.
  • Per Iovance Biotherapeutics' latest filing, its Other Operating Expenses stood at $124.0 million for FY2024, which was up 1,052.91% from $10.8 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Other Operating Expenses registered a high of $124.0 million during FY2024, and its lowest value of $10.8 million during FY2023.
  • In the last 2 years, Iovance Biotherapeutics' Other Operating Expenses had a median value of $67.4 million in 2023 and averaged $67.4 million.
  • Data for Iovance Biotherapeutics' Other Operating Expenses shows a peak YoY skyrocketed of 1,052.91% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Other Operating Expenses (Yearly) stood at $10.8 million in 2023, then surged by 1,052.91% to $124.0 million in 2024.